CES Sticks With No-Booster Policy Amid Pfizer’s Troubling Omicron Finding
With about three weeks before CES 2022 opens in Las Vegas, there’s no change in CTA policy not requiring a COVID-19 booster shot “at this time” to attend the in-person Jan. 5-8 show, emailed a spokesperson Tuesday. CTA considers CES…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
participants fully vaccinated if they got their second dose of a multi-dose vaccine like the Pfizer or Moderna or the single dose of the Johnson & Johnson at least 14 days before picking up a badge. Imposing a CES booster mandate now for those collecting a badge on the show’s opening morning would require proof of the extra dose at least three days before Christmas. The CTA spokesperson sidestepped our questions about Pfizer’s Dec. 8 report showing a 25-fold reduction in protection against the new omicron variant among people with two Pfizer doses, but not the booster. Getting the booster restores the protection against omicron to levels approaching those of the original two doses, said Pfizer. “We are actively tracking the emerging news and science around the new Omicron variant,” say CTA’s CES 2022 health and safety protocols posted weeks ago and still active Tuesday at the show's website. “While it is too early to determine the impact of this latest variant, we will continue to monitor and adjust our plans and health protocols as necessary.”